According to the research report titled ‘Global Cotinine Screening Devices Market Analysis, 2020’, available with Market Study Report, worldwide cotinine screening devices market is expected to witness a y-o-y growth rate of 5% between 2020 and 2025.
 

Increasing direct and indirect consumption of tobacco coupled with high pervasiveness of cardiovascular diseases are some of the key factors driving the growth of global cotinine screening devices market. As per the World Health Organization (WHO), tobacco is responsible for 8 million deaths across the globe each year, with around 80% of global smokers living in middle to low income countries.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3114647/
 

Cotinine is a chemical which is generated by a body after being exposed to nicotine. In this regard, cotinine screening is a test that measures the cotinine amount in urine. This urine sample is utilized to diagnose tobacco and nicotine content in the human body. Growing trends of drug testing during pre-employment processes in workplaces is also aiding the expansion of global cotinine screening devices industry.
 

Based on device type, the market is segmented into readers, strips, and cassettes. In terms of sample type, the industry is bifurcated into urine sample, saliva sample, and blood sample. The end-user scope of global cotinine screening devices market consists of workplace screening centers, clinics, laboratories, and hospitals.
 

Considering the geographical landscape, global cotinine market is split into North America, Asia-Pacific, Middle East & Africa, Europe, and Latin America. The report states that North America is expected to account for the largest market share by 2025, with United States leading the revenue hierarchy.
 

Mounting number of smokers and tobacco consumers and subsequent increase in number of smoking-related deaths coupled with strict regulatory outlook are some of the major factors positively influencing the business dynamics in North America.
 

Parallelly, Asia-Pacific cotinine screening devices industry is estimated to record a robust CAGR through 2025, primarily due to increasing number of smokers and high occurrence of cardiovascular diseases.
 

Germaine Laboratories Inc., Ameritek USA Inc., Nano Ditech Corp., LifeSign LLC, Abbott Laboratories, Mossman Associates, Sinocare Inc., Jant Pharmacal Corporation, AlcoPro Inc., and Alfa Scientific Designs Inc. are the key competitors in global cotinine screening devices market.